PetCaseFinder

Peer-reviewed veterinary case report

Recombinant distemper vaccine protects shelter dogs exposed right

By Larson, L J & Schultz, R D·Published in Veterinary therapeutics : research in applied veterinary medicine·2006·Department of Pathobiological Sciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Effect of vaccination with recombinant canine distemper virus vaccine immediately before exposure under shelter-like conditions.

Species:
dog

Plain-English summary

A group of dogs was vaccinated with a new type of canine distemper virus (CDV) vaccine just hours before being exposed to the virus in a high-risk environment. The vaccinated dogs did not get sick, while unvaccinated dogs became ill and unfortunately died. Dogs that received the vaccine a week before exposure also stayed healthy. This study suggests that the new vaccine can provide quick protection against CDV, making it a good option for dogs in shelters or kennels.

People also search for: dog distemper vaccine effectiveness · puppy vaccination before exposure · canine distemper virus symptoms

Abstract

Vaccination with modified-live virus (MLV) canine distemper virus (CDV) vaccine has historically been recommended for animals in high-risk environments because of the rapid onset of immunity following vaccination. Recombinant CDV (rCDV) vaccine was deemed a suitable alternative to MLV-CDV vaccination in pet dogs, but insufficient data precluded its use where CDV was a serious threat to puppies, such as in shelters, kennels, and pet stores. In this study, dogs experimentally challenged hours after a single dose of rCDV or MLV vaccine became sick but recovered, whereas unvaccinated dogs became sick and died. Dogs vaccinated with a single dose of rCDV or MLV vaccine 1 week before being experimentally challenged remained healthy and showed no clinical signs. Dogs given one dose of rCDV vaccine hours before being placed in a CDV-contaminated environment did not become sick. These findings support the hypothesis that rCDV vaccine has a similar time-to-immunity as MLV-CDV vaccines and can likewise protect dogs in high-risk environments after one dose.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/16871493/